The FDA, in its commitment to provide stakeholders with streamlined and improved government services, is developing the FDA eServices Portal System – an online platform for FDA marketing authorization applications.
The FDA wishes to invite stakeholders to use the FDA eServices Portal System through https://eservices.fda.gov.ph for PCPR Conversion applications. The eServices Portal is in its Pilot Implementation; hence, the scope of the application is limited for the time being:
| FDA eServices Portal Pilot Implementation for
PCPR Conversion Applications |
|
| Transactions | PCPR Conversion |
| Fees to be Paid | Based on Current Issuance on Fees and Charges (DOH Administrative Order No. 50, s. 2001) |
| Start of Pilot Implementation | 26 July 2021 |
| End of Pilot Implementation | 26 August 2021 |
Please follow Annex A of this Advisory for the Guidelines on PCPR Conversion Applications Using eServices Portal System and Annex B for Procedure on the Use of the FDA eServices Portal System for PCPR Conversion Application.
For comments and suggestions on the FDA eServices Portal, please send them to [email protected].